Fusion event
HBV-chr19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CGCCCACCAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTT| |AAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTT
End
28741609/28250702 (Hg38)
Nearest miRNA
hsa-mir-10395/Upstream/7851348; hsa-let-7e/Downstream/6871998;
Upstream sequence
gagctgcaatgacaagtgcttctcaagtctctgcttgtgtcattttcggctgatatcctatggccaacaacaagctacgtAATTTGTGACCATTTTTGTG
Downstream sequence
ATTTACCATAGACAATTCTAAGATCACCTGCTTAGAATTTAAAGAGAATCGGCTAATTTAAACATGAAATATTAAAACTATATAAGCCAGACATAGAAAA
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.